Replay available

Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call

Neumora Therapeutics, Inc. (NASDAQ: NMRA) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.

Wed, August 6, 2025 at 4:30 PMendedReplay
Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call

Hosted by

Featured presenters

Helen Robinson

Vice President of Investor Relations and Communications

Paul Burns

Chief Executive Officer

Josh Pinto

President

Mike Milligan

Chief Financial Officer

Yatin Soneja

Analyst, Guggenheim

Douglas H.C. Wainwright

Analyst

Myles Minter

Analyst, William Blair

Ami Fadia

Analyst, NIDAM

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Neumora Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.374 Ladies and gentlemen, thank you for standing by. 00:00:02.374 -- 00:00:05.278 This is RG, your conference operator today. 00:00:05.278 -- 00:00:09.403 At this time, all participants are in a listen-only mode. 00:00:09.403 -- 00:00:13.949 After the speaker's presentation, there will be a question and answer session. 00:00:13.949 -- 00:00:17.634 Please be advised that today's conference is being recorded. 00:00:17.634 -- 00:00:22.760 I would like now to turn the conference over to Helen Robinson, Vice President 00:00:22.760 -- 00:00:25.604 of Investor Relations and Communications. 00:00:25.604 -- 00:00:28.094 Please go ahead. 00:00:28.094 -- 00:00:32.999 Good afternoon, and thank you for joining Numora Therapeutics' second quarter 2025 financial 00:00:32.999 -- 00:00:37.705 results conference call. Before we begin, I encourage everyone to go to the investors 00:00:37.705 -- 00:00:42.009 and media section of our website at numoratx.com, 00:00:42.009 -- 00:00:45.233 where you can find the press release related to today's call. 00:00:45.233 -- 00:00:50.339 With me today from Numora are Chief Executive Officer Paul Burns, President Josh 00:00:50.339 -- 00:00:55.504 Pinto, Chief Operating and Development Officer Bill Arora, Chief Scientific Officer 00:00:55.504 -- 00:00:58.340 Nick Brandon, and Chief Financial Officer Mike Milligan. 00:00:58.340 -- 00:01:03.245 I'd like to point out that we will be making forward-looking statements, which are based 00:01:03.245 -- 00:01:07.689 on our current expectations and beliefs. These statements are subject to certain risks 00:01:07.689 -- 00:01:11.793 and uncertainties, and our actual results may differ materially. 00:01:11.793 -- 00:01:15.837 Please review the risk factors discussed in today's pres...